List of Tables
Table 1. Global Antimicrobial Peptides Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Antimicrobial Peptides Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Antimicrobial Peptides Market Competitive Situation by Manufacturers in 2025
Table 4. Global Antimicrobial Peptides Sales (Mg) of Key Manufacturers (2021–2026)
Table 5. Global Antimicrobial Peptides Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Antimicrobial Peptides Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Antimicrobial Peptides Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Antimicrobial Peptides Average Price (US$/Mg) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Antimicrobial Peptides, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Antimicrobial Peptides, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Antimicrobial Peptides, Product Types and Applications
Table 12. Global Key Manufacturers of Antimicrobial Peptides, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Antimicrobial Peptides Companies by Tier (Tier 1, Tier 2, Tier 3), based on Antimicrobial Peptides Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Antimicrobial Peptides Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Antimicrobial Peptides Sales by Region (Mg), 2021–2026
Table 18. Global Antimicrobial Peptides Sales Market Share by Region (2021–2026)
Table 19. Global Antimicrobial Peptides Sales by Region (Mg), 2027–2032
Table 20. Global Antimicrobial Peptides Sales Market Share by Region (2027–2032)
Table 21. Global Antimicrobial Peptides Revenue by Region (US$ Million), 2021–2026
Table 22. Global Antimicrobial Peptides Revenue Market Share by Region (2021–2026)
Table 23. Global Antimicrobial Peptides Revenue by Region (US$ Million), 2027–2032
Table 24. Global Antimicrobial Peptides Revenue Market Share by Region (2027–2032)
Table 25. North America Antimicrobial Peptides Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Antimicrobial Peptides Sales by Country (Mg), 2021–2026
Table 27. North America Antimicrobial Peptides Sales by Country (Mg), 2027–2032
Table 28. North America Antimicrobial Peptides Revenue by Country (US$ Million), 2021–2026
Table 29. North America Antimicrobial Peptides Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Antimicrobial Peptides Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Antimicrobial Peptides Sales by Country (Mg), 2021–2026
Table 32. Europe Antimicrobial Peptides Sales by Country (Mg), 2027–2032
Table 33. Europe Antimicrobial Peptides Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Antimicrobial Peptides Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Antimicrobial Peptides Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Antimicrobial Peptides Sales by Region (Mg), 2021–2026
Table 37. Asia Pacific Antimicrobial Peptides Sales by Region (Mg), 2027–2032
Table 38. Asia Pacific Antimicrobial Peptides Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Antimicrobial Peptides Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Antimicrobial Peptides Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Antimicrobial Peptides Sales by Country (Mg), 2021–2026
Table 42. Latin America Antimicrobial Peptides Sales by Country (Mg), 2027–2032
Table 43. Latin America Antimicrobial Peptides Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Antimicrobial Peptides Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Antimicrobial Peptides Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Antimicrobial Peptides Sales by Country (Mg), 2021–2026
Table 47. Middle East and Africa Antimicrobial Peptides Sales by Country (Mg), 2027–2032
Table 48. Middle East and Africa Antimicrobial Peptides Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Antimicrobial Peptides Revenue by Country (US$ Million), 2027–2032
Table 50. Global Antimicrobial Peptides Sales (Mg) by Type (2021–2026)
Table 51. Global Antimicrobial Peptides Sales (Mg) by Type (2027–2032)
Table 52. Global Antimicrobial Peptides Sales Market Share by Type (2021–2026)
Table 53. Global Antimicrobial Peptides Sales Market Share by Type (2027–2032)
Table 54. Global Antimicrobial Peptides Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Antimicrobial Peptides Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Antimicrobial Peptides Revenue Market Share by Type (2021–2026)
Table 57. Global Antimicrobial Peptides Revenue Market Share by Type (2027–2032)
Table 58. Global Antimicrobial Peptides Price (US$/Mg) by Type (2021–2026)
Table 59. Global Antimicrobial Peptides Price (US$/Mg) by Type (2027–2032)
Table 60. Global Antimicrobial Peptides Sales (Mg) by Application (2021–2026)
Table 61. Global Antimicrobial Peptides Sales (Mg) by Application (2027–2032)
Table 62. Global Antimicrobial Peptides Sales Market Share by Application (2021–2026)
Table 63. Global Antimicrobial Peptides Sales Market Share by Application (2027–2032)
Table 64. Global Antimicrobial Peptides Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Antimicrobial Peptides Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Antimicrobial Peptides Revenue Market Share by Application (2021–2026)
Table 67. Global Antimicrobial Peptides Revenue Market Share by Application (2027–2032)
Table 68. Global Antimicrobial Peptides Price (US$/Mg) by Application (2021–2026)
Table 69. Global Antimicrobial Peptides Price (US$/Mg) by Application (2027–2032)
Table 70. AnaSpec Company Information
Table 71. AnaSpec Description and Business Overview
Table 72. AnaSpec Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg), and Gross Margin (2021–2026)
Table 73. AnaSpec Antimicrobial Peptides Product
Table 74. AnaSpec Recent Developments/Updates
Table 75. AMP Biotech Company Information
Table 76. AMP Biotech Description and Business Overview
Table 77. AMP Biotech Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg), and Gross Margin (2021–2026)
Table 78. AMP Biotech Antimicrobial Peptides Product
Table 79. AMP Biotech Recent Developments/Updates
Table 80. Phoenix Biotech Company Information
Table 81. Phoenix Biotech Description and Business Overview
Table 82. Phoenix Biotech Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg), and Gross Margin (2021–2026)
Table 83. Phoenix Biotech Antimicrobial Peptides Product
Table 84. Phoenix Biotech Recent Developments/Updates
Table 85. Novabiotics Company Information
Table 86. Novabiotics Description and Business Overview
Table 87. Novabiotics Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg), and Gross Margin (2021–2026)
Table 88. Novabiotics Antimicrobial Peptides Product
Table 89. Novabiotics Recent Developments/Updates
Table 90. Chinese Peptide Company Information
Table 91. Chinese Peptide Description and Business Overview
Table 92. Chinese Peptide Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg), and Gross Margin (2021–2026)
Table 93. Chinese Peptide Antimicrobial Peptides Product
Table 94. Chinese Peptide Recent Developments/Updates
Table 95. Ontores Company Information
Table 96. Ontores Description and Business Overview
Table 97. Ontores Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg), and Gross Margin (2021–2026)
Table 98. Ontores Antimicrobial Peptides Product
Table 99. Ontores Recent Developments/Updates
Table 100. GenScript Company Information
Table 101. GenScript Description and Business Overview
Table 102. GenScript Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg), and Gross Margin (2021–2026)
Table 103. GenScript Antimicrobial Peptides Product
Table 104. GenScript Recent Developments/Updates
Table 105. Hycult Biotech Company Information
Table 106. Hycult Biotech Description and Business Overview
Table 107. Hycult Biotech Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg), and Gross Margin (2021–2026)
Table 108. Hycult Biotech Antimicrobial Peptides Product
Table 109. Hycult Biotech Recent Developments/Updates
Table 110. Sunsmile Company Information
Table 111. Sunsmile Description and Business Overview
Table 112. Sunsmile Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg), and Gross Margin (2021–2026)
Table 113. Sunsmile Antimicrobial Peptides Product
Table 114. Sunsmile Recent Developments/Updates
Table 115. Ruixing Biotechnology Company Information
Table 116. Ruixing Biotechnology Description and Business Overview
Table 117. Ruixing Biotechnology Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg), and Gross Margin (2021–2026)
Table 118. Ruixing Biotechnology Antimicrobial Peptides Product
Table 119. Ruixing Biotechnology Recent Developments/Updates
Table 120. Zhongnong Yingtai Biotechnology Company Information
Table 121. Zhongnong Yingtai Biotechnology Description and Business Overview
Table 122. Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg), and Gross Margin (2021–2026)
Table 123. Zhongnong Yingtai Biotechnology Antimicrobial Peptides Product
Table 124. Zhongnong Yingtai Biotechnology Recent Developments/Updates
Table 125. Glam Technology Company Information
Table 126. Glam Technology Description and Business Overview
Table 127. Glam Technology Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg), and Gross Margin (2021–2026)
Table 128. Glam Technology Antimicrobial Peptides Product
Table 129. Glam Technology Recent Developments/Updates
Table 130. ProteLight Pharmaceutical & Biotechnology Company Information
Table 131. ProteLight Pharmaceutical & Biotechnology Description and Business Overview
Table 132. ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg), and Gross Margin (2021–2026)
Table 133. ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Product
Table 134. ProteLight Pharmaceutical & Biotechnology Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Antimicrobial Peptides Distributors List
Table 138. Antimicrobial Peptides Customers List
Table 139. Antimicrobial Peptides Market Trends
Table 140. Antimicrobial Peptides Market Drivers
Table 141. Antimicrobial Peptides Market Challenges
Table 142. Antimicrobial Peptides Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Product Picture of Antimicrobial Peptides
Figure 2. Global Antimicrobial Peptides Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Antimicrobial Peptides Market Share by Type: 2025 & 2032
Figure 4. Plant Antimicrobial Peptides Product Picture
Figure 5. Microbial Antimicrobial Peptides Product Picture
Figure 6. Animal Antimicrobial Peptides Product Picture
Figure 7. Global Antimicrobial Peptides Market Value by Application (US$ Million), 2021–2032
Figure 8. Global Antimicrobial Peptides Market Share by Application: 2025 & 2032
Figure 9. Pharmaceuticals
Figure 10. Feed Additives
Figure 11. Others
Figure 12. Global Antimicrobial Peptides Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Antimicrobial Peptides Market Size (US$ Million), 2021–2032
Figure 14. Global Antimicrobial Peptides Sales (Mg), 2021–2032
Figure 15. Global Antimicrobial Peptides Average Price (US$/Mg), 2021–2032
Figure 16. Antimicrobial Peptides Report Years Considered
Figure 17. Antimicrobial Peptides Sales Share by Manufacturers in 2025
Figure 18. Global Antimicrobial Peptides Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Antimicrobial Peptides Players: Market Share by Revenue in Antimicrobial Peptides in 2025
Figure 20. Antimicrobial Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Antimicrobial Peptides Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Antimicrobial Peptides Sales Market Share by Country (2021–2032)
Figure 23. North America Antimicrobial Peptides Revenue Market Share by Country (2021–2032)
Figure 24. U.S. Antimicrobial Peptides Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Antimicrobial Peptides Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Antimicrobial Peptides Sales Market Share by Country (2021–2032)
Figure 27. Europe Antimicrobial Peptides Revenue Market Share by Country (2021–2032)
Figure 28. Germany Antimicrobial Peptides Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Antimicrobial Peptides Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Antimicrobial Peptides Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Antimicrobial Peptides Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Antimicrobial Peptides Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Antimicrobial Peptides Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Antimicrobial Peptides Revenue Market Share by Region (2021–2032)
Figure 35. China Antimicrobial Peptides Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Antimicrobial Peptides Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Antimicrobial Peptides Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Antimicrobial Peptides Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Antimicrobial Peptides Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Taiwan Antimicrobial Peptides Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Indonesia Antimicrobial Peptides Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Thailand Antimicrobial Peptides Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Malaysia Antimicrobial Peptides Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Philippines Antimicrobial Peptides Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Latin America Antimicrobial Peptides Sales Market Share by Country (2021–2032)
Figure 46. Latin America Antimicrobial Peptides Revenue Market Share by Country (2021–2032)
Figure 47. Mexico Antimicrobial Peptides Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Brazil Antimicrobial Peptides Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Argentina Antimicrobial Peptides Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Middle East and Africa Antimicrobial Peptides Sales Market Share by Country (2021–2032)
Figure 51. Middle East and Africa Antimicrobial Peptides Revenue Market Share by Country (2021–2032)
Figure 52. Turkey Antimicrobial Peptides Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Saudi Arabia Antimicrobial Peptides Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. UAE Antimicrobial Peptides Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Global Sales Market Share of Antimicrobial Peptides by Type (2021–2032)
Figure 56. Global Revenue Market Share of Antimicrobial Peptides by Type (2021–2032)
Figure 57. Global Antimicrobial Peptides Price (US$/Mg) by Type (2021–2032)
Figure 58. Global Sales Market Share of Antimicrobial Peptides by Application (2021–2032)
Figure 59. Global Revenue Market Share of Antimicrobial Peptides by Application (2021–2032)
Figure 60. Global Antimicrobial Peptides Price (US$/Mg) by Application (2021–2032)
Figure 61. Antimicrobial Peptides Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
